Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREVENA NPWT for Infection Prevention in TKA
NCT02118558Phase 2Unknown
- Sponsor
- Hadassah Medical Organization
- Start
- Jun 2014
- Primary completion
- Jan 2016
01
Overview
Phase 2, randomised, open-label trial (2 arms), sponsored by Hadassah Medical Organization. Primary endpoint: Proportion of infections at the treatment and control groups after six weeks at 6 weeks. Status: unknown.
Beyond the preview
Go deeper on NCT02118558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02118558.